NO305931B1 - Fremgangsmåte for fremstilling av en blanding for kontrollert avgivelse av biologisk aktive midler - Google Patents

Fremgangsmåte for fremstilling av en blanding for kontrollert avgivelse av biologisk aktive midler

Info

Publication number
NO305931B1
NO305931B1 NO931832A NO931832A NO305931B1 NO 305931 B1 NO305931 B1 NO 305931B1 NO 931832 A NO931832 A NO 931832A NO 931832 A NO931832 A NO 931832A NO 305931 B1 NO305931 B1 NO 305931B1
Authority
NO
Norway
Prior art keywords
biologically active
active agents
crystalline phase
liquid crystalline
composition
Prior art date
Application number
NO931832A
Other languages
English (en)
Norwegian (no)
Other versions
NO931832D0 (no
NO931832L (no
Inventor
Pia Lading
Yvonne Lundsholm
Tomas Norling
Original Assignee
Dumex Ltd As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dumex Ltd As filed Critical Dumex Ltd As
Publication of NO931832D0 publication Critical patent/NO931832D0/no
Publication of NO931832L publication Critical patent/NO931832L/no
Publication of NO305931B1 publication Critical patent/NO305931B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
NO931832A 1990-11-21 1993-05-19 Fremgangsmåte for fremstilling av en blanding for kontrollert avgivelse av biologisk aktive midler NO305931B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/DK1990/000299 WO1992009272A1 (en) 1990-11-21 1990-11-21 Method and composition for controlled delivery of biologically active agents
CA002095354A CA2095354C (en) 1990-11-21 1990-11-21 Method and composition for controlled delivery of biologically active agents

Publications (3)

Publication Number Publication Date
NO931832D0 NO931832D0 (no) 1993-05-19
NO931832L NO931832L (no) 1993-07-19
NO305931B1 true NO305931B1 (no) 1999-08-23

Family

ID=25676134

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931832A NO305931B1 (no) 1990-11-21 1993-05-19 Fremgangsmåte for fremstilling av en blanding for kontrollert avgivelse av biologisk aktive midler

Country Status (15)

Country Link
US (1) US5143934A (ko)
EP (1) EP0558475B1 (ko)
JP (1) JPH03135925A (ko)
KR (1) KR0180750B1 (ko)
AT (1) ATE115402T1 (ko)
AU (1) AU647768B2 (ko)
CA (1) CA2095354C (ko)
DE (1) DE69015212T2 (ko)
DK (1) DK0558475T3 (ko)
ES (1) ES2065670T3 (ko)
FI (1) FI109452B (ko)
GR (1) GR3015329T3 (ko)
HU (1) HU220216B (ko)
NO (1) NO305931B1 (ko)
WO (1) WO1992009272A1 (ko)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
US5371109A (en) * 1986-07-01 1994-12-06 Drilletten Ab Controlled release composition for a biologically active material dissolved or dispersed in an L2-phase
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5620700A (en) * 1990-10-30 1997-04-15 Alza Corporation Injectable drug delivery system and method
US5531925A (en) * 1991-10-04 1996-07-02 Gs Biochem Ab Particles, method of preparing said particles and uses thereof
US5447725A (en) * 1993-06-11 1995-09-05 The Procter & Gamble Company Methods for aiding periodontal tissue regeneration
US5538954A (en) * 1994-06-24 1996-07-23 A/S Dumex (Dumex Ltd.) Salts of tetracyclines
WO1995017901A1 (en) * 1993-12-29 1995-07-06 Matrix Pharmaceutical, Inc. Methods and compositions for the treatment of a host with a cellular proliferative disease
ATE333867T1 (de) * 1994-03-18 2006-08-15 Shire Lab Inc Emulgierte arzneistoffabgabesysteme
AU2593695A (en) * 1994-05-20 1995-12-18 Novavax, Inc. Antibacterial oil-in-water emulsions
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
US5744062A (en) * 1996-08-29 1998-04-28 R.I.T.A. Corporation Balanced emulsifier blends for oil-in-water emulsions
EP1033127A4 (en) 1997-03-18 2006-07-26 Sunstar Inc COMPOSITIONS FOR THE FORMATION OF SOLID-PARTICULAR PARTICLES
ES2202901T3 (es) 1997-09-09 2004-04-01 Lyotropic Therapeutics, Inc. Particulas recubiertas, procedimiento para su fabricacion y uso.
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
US6017516A (en) * 1997-10-31 2000-01-25 Lekar Pharma Limited Pharmaceutical dental formulation for topical application of metronidazole benzoate and chlorhexidine gluconate
GB9827034D0 (en) * 1998-12-10 1999-02-03 Univ Manchester Delivery formulation
GB0001449D0 (en) * 2000-01-21 2000-03-08 Cortendo Ab Compositions
US6423707B1 (en) 2000-08-28 2002-07-23 California Pacific Medical Center Nitroimidazole ester analogues and therapeutic applications
JP2003171301A (ja) * 2001-11-09 2003-06-20 Mahidol Univ 歯周炎治療における補助剤としてのカルメグゲル
AU2003258075A1 (en) * 2002-08-06 2004-02-23 Lyotropic Therapeutics, Inc. Lipid-drug complexes in reversed liquid and liquid crystalline phases
MXPA05002033A (es) 2002-08-26 2005-10-19 Sla Pharma Ag Una composicion farmaceutica.
CA2502734A1 (en) * 2002-08-29 2004-03-11 Toray Industries, Inc. Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient
DK1415646T3 (da) * 2002-11-01 2009-12-21 Univ Mahidol Gel omfattende et antimikrobielt ekstrakt som tilsætningsmiddel i behandlingen af periodontitis
DE10332680A1 (de) * 2003-07-18 2005-02-17 Biomet Deutschland Gmbh Verwendung von antiseptischen Wirkstoffen in PMMA-Knochenzementen
WO2005027807A1 (en) 2003-09-19 2005-03-31 Drugtech Corporation Pharmaceutical delivery system
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
WO2006043705A1 (ja) * 2004-10-19 2006-04-27 National Institute Of Advanced Industrial Scienceand Technology Ｉｉ型キュービック液晶組成物
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
AR048742A1 (es) * 2004-12-22 2006-05-24 Gador Sa Sistema de aplicacion de medicamentos intra-oral
US7125954B2 (en) * 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
MX2007011464A (es) * 2005-03-18 2007-10-12 Lg Household & Health Care Ltd Blanqueador dental.
AU2006244260A1 (en) * 2005-05-09 2006-11-16 Drugtech Corporation Modified-release pharmaceutical compositions
US20080219935A1 (en) * 2005-07-08 2008-09-11 Sang-Hoon Kwak Phase Transitive Breath Care Products
AU2006332518A1 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Composition and method of use thereof
US20070154516A1 (en) * 2006-01-05 2007-07-05 Drugtech Corporation Drug delivery system
US20100105750A1 (en) * 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
EP2498754B1 (en) * 2009-06-25 2018-06-06 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Reverse hexagonal mesophases (h ii) and uses thereof
WO2011001425A1 (en) 2009-07-01 2011-01-06 Dexcel Pharma Technologies Ltd. Local therapeutic release device
US8865198B2 (en) 2010-10-25 2014-10-21 Dexcel Pharma Technologies Ltd. Method for treating a periodontal disease
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US8895536B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating chronic inflammation and inflammatory diseases
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
RU2508101C1 (ru) * 2012-10-16 2014-02-27 Открытое акционерное общество "Биосинтез" Мягкая лекарственная форма комбинированного действия для локального лечения заболеваний пародонта
SG11201505245XA (en) * 2013-01-14 2015-08-28 Infirst Healthcare Ltd Compositions and methods for treating severe pain
CA2897878A1 (en) * 2013-01-14 2014-07-17 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
SG11201505243PA (en) * 2013-02-04 2015-08-28 Infirst Healthcare Ltd Compositions and methods for treating chronic inflammation and inflammatory diseases
WO2014175814A1 (en) * 2013-04-26 2014-10-30 Bioglan Ab Composition for use in reducing scab formation and promoting healing

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2196322A (en) * 1937-12-04 1940-04-09 Squibb & Sons Inc Pharmaceutical
DK116528A (ko) * 1966-09-30
US4568535A (en) * 1982-08-06 1986-02-04 Loesche Walter J Composition for periodontal administration
US4698359A (en) * 1982-08-24 1987-10-06 Cilag, Ag Medicated suppository
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
EP1169958A1 (en) * 2000-06-28 2002-01-09 Tege Patents Aktiengesellschaft Vending machine cooking unit

Also Published As

Publication number Publication date
HUT75453A (en) 1997-05-28
EP0558475B1 (en) 1994-12-14
NO931832D0 (no) 1993-05-19
HU9301346D0 (en) 1993-09-28
HU220216B (hu) 2001-11-28
WO1992009272A1 (en) 1992-06-11
FI932278A0 (fi) 1993-05-19
GR3015329T3 (en) 1995-06-30
KR0180750B1 (ko) 1999-03-20
ATE115402T1 (de) 1994-12-15
DE69015212T2 (de) 1995-05-04
US5143934A (en) 1992-09-01
AU7049991A (en) 1992-06-25
JPH03135925A (ja) 1991-06-10
ES2065670T3 (es) 1995-02-16
FI109452B (fi) 2002-08-15
AU647768B2 (en) 1994-03-31
FI932278A (fi) 1993-05-19
DK0558475T3 (da) 1995-04-24
DE69015212D1 (de) 1995-01-26
NO931832L (no) 1993-07-19
CA2095354C (en) 2001-10-09
EP0558475A1 (en) 1993-09-08
CA2095354A1 (en) 1992-05-22

Similar Documents

Publication Publication Date Title
NO305931B1 (no) Fremgangsmåte for fremstilling av en blanding for kontrollert avgivelse av biologisk aktive midler
AR007715A1 (es) Formulacion acuosa estable de un peptido, un metodo para preparar la misma y su uso para tratamiento
ZA93215B (en) Pharmaceutical formulation in the form of an effervescent and/or disintegrating tablet of instant granules, and process for its preparation.
DE69331839T2 (de) Schnellösliche Tablette und ihre Herstellung
CA2140545A1 (en) Use of first runnings coconut fatty acid as insect-repellent
EP0133170A3 (en) A compound and a composition for therapeutic or diagnostic use and a method for therapeutic treatment
DE69427661D1 (de) Glutaraldehydzusammensetzung
JP2004537546A5 (ko)
RU93034455A (ru) Композиция для контролируемой подачи биологически активных агентов, способ контролируемого высвобождения биологически активного агента, способ лечения периодонтальной болезни
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
NZ505080A (en) Pharmaceutical formulations containing a compound having an amidine group stabilized by an acid
KR960702449A (ko) 3-이소프로필-2, 1, 3-벤조티아디아진-4-온 2, 2-디옥사이드의 마그네슘염, 그의 제조방법 및 바람직하지 못한 식물 성장 억제를 위한 이들의 용도(Magnesium salt of 3-Isopropyl-2.1.3-Benzothiadiazin-4-one 2,2-Dioxide, Method of Preparing it and its Use in the Control of Undesirable Plant Growth)
KR900016130A (ko) 2-피리딜메틸티오 유도체 및 궤양 치료제
BG60542B2 (en) Water soluble composition having coccidiostatic effect
ES2011472B3 (es) Procedimiento para el tratamiento de soluciones acuosas producidas en la carboxilacion de compuestos olefinicos no saturados.
JPS51151383A (en) Process for cultivating excrement- deodorizing bacteria
JPS57146708A (en) Novel oral preparation
JPS5762236A (en) Novel preparation of 4-hydroxy-2-cyclopentenone
JPS553807A (en) Manufacture of deodorant using organic substance
RU1135169C (ru) Способ получения бактерицидных смесей
ATE52994T1 (de) Fluessige, biologisch wirksame zusammensetzungen.
HUP9902478A2 (hu) Vírusellenes gyógyszerkészítmények és eljárás azok előállítására
JPS642536A (en) Production of feed comprising activated sludge as main component
TH2453EX (th) สูตรผสมยาฆ่าพยาธิชนิดที่ละลายน้ำได้น้อยและกรรมวิธีสำหรับการเตรียมสูตรผสมต่าง ๆ นี้
JPS642537A (en) Attractant for fishes

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees